Despite efforts to reduce antibiotic prescribing for acute respiratory infections (ARIs), information on factors that drive prescribing is limited.
To examine trends in antibiotic prescribing in the Veterans Affairs population over an 8-year period and to identify patient, provider, and setting sources of variation.
Retrospective, cross-sectional study.
All emergency departments and primary and urgent care clinics in the Veterans Affairs health system.
All patient visits between 2005 and 2012 with primary diagnoses of ARIs that typically had low proportions of bacterial infection. Patients with infections or comorbid conditions that indicated antibiotic use were excluded.
Overall antibiotic prescription; macrolide prescription; and patient, provider, and setting characteristics extracted from the electronic health record.
The proportion of 1 million visits with ARI diagnoses that resulted in antibiotic prescriptions increased from 67.5% in 2005 to 69.2% in 2012 (P < 0.001). The proportion of macrolide antibiotics prescribed increased from 36.8% to 47.0% (P < 0.001). Antibiotic prescribing was highest for sinusitis (adjusted proportion, 86%) and bronchitis (85%) and varied little according to fever, age, setting, or comorbid conditions. Substantial variation was identified in prescribing at the provider level: The 10% of providers who prescribed the most antibiotics did so during at least 95% of their ARI visits, and the 10% who prescribed the least did so during 40% or fewer of their ARI visits.
Some clinical data that may have influenced the prescribing decision were missing.
Veterans with ARIs commonly receive antibiotics, regardless of patient, provider, or setting characteristics. Macrolide use has increased, and substantial variation was identified in antibiotic prescribing at the provider level.
Primary Funding Source:
U.S. Department of Veterans Affairs, Centers for Disease Control and Prevention.
Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al; Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:155-64. [PMID: 18171244] doi: 10.1086/524891CrossrefMedlineGoogle Scholar
McCarthy M. CDC calls for urgent action to combat rise of drug resistant pathogens. BMJ. 2013;347:f5649. [PMID: 24046289] doi: 10.1136/bmj.f5649CrossrefMedlineGoogle Scholar
Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J Antimicrob Chemother. 2014;69:234-40. [PMID: 23887867] doi: 10.1093/jac/dkt301CrossrefMedlineGoogle Scholar
Roumie CL, Halasa NB, Grijalva CG, Edwards KM, Zhu Y, Dittus RS, et al. Trends in antibiotic prescribing for adults in the United States—1995 to 2002. J Gen Intern Med. 2005;20:697-702. [PMID: 16050877] CrossrefMedlineGoogle Scholar
Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001;134:479-86. [PMID: 11255524] LinkGoogle Scholar
- 6. Centers for Disease Control and Prevention. Get Smart: Know When Antibiotics Work. Adult Treatment Recommendations. Accessed at www.cdc.gov/getsmart/community/for-hcp/outpatient-hcp/adult-treatment-rec.html on 24 May 2015. Google Scholar
Centers for Disease Control and Prevention (CDC). Office-related antibiotic prescribing for persons aged ≤14 years—United States, 1993–1994 to 2007–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1153-6. [PMID: 21881545] MedlineGoogle Scholar
Lee GC, Reveles KR, Attridge RT, Lawson KA, Mansi IA, Lewis JS 2nd, et al. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC Med. 2014;12:96. [PMID: 24916809] doi: 10.1186/1741-7015-12-96CrossrefMedlineGoogle Scholar
Hicks LA, Taylor TH Jr, Hunkler RJ. U.S. outpatient antibiotic prescribing, 2010 [Letter]. N Engl J Med. 2013;368:1461-2. [PMID: 23574140] doi: 10.1056/NEJMc1212055CrossrefMedlineGoogle Scholar
Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in U.S. ambulatory settings. JAMA. 2009;302:758-66. [PMID: 19690308] doi: 10.1001/jama.2009.1163CrossrefMedlineGoogle Scholar
Aspinall SL, Berlin JA, Zhang Y, Metlay JP. Facility-level variation in antibiotic prescriptions for veterans with upper respiratory infections. Clin Ther. 2005;27:258-62. [PMID: 15811491] CrossrefMedlineGoogle Scholar
Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 2003;289:719-25. [PMID: 12585950] CrossrefMedlineGoogle Scholar
Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901-4. [PMID: 9302241] CrossrefMedlineGoogle Scholar
- 14. Office of Quality, Safety and Value. 2012 VHA Facility Quality and Safety Report. Washington, DC: Department of Veterans Affairs; 2012. Accessed at www.va.gov/HEALTH/docs/2012_VHA_Facility_Quality_and_Safety_Report_FINAL508.pdf on 25 May 2015. Google Scholar
- 15. U.S. Department of Veterans Affairs. VA Informatics and Computing Infrastructure (VINCI). Accessed at www.hsrd.research.va.gov/for_researchers/vinci on 25 May 2015. Google Scholar
Boyko EJ, Koepsell TD, Gaziano JM, Horner RD, Feussner JR. U.S. Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol. 2000;151:307-14. [PMID: 10670556] CrossrefMedlineGoogle Scholar
- 17. Agency for Healthcare Research and Quality. Clinical Classifications Software (CCS) for ICD-9-CM Fact Sheet. Rockville, MD: Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality; 2012. Accessed at www.hcup-us.ahrq.gov/toolssoftware/ccs/ccsfactsheet.jsp on 15 May 2014. Google Scholar
Bui DD, Zeng-Treitler Q. Learning regular expressions for clinical text classification. J Am Med Inform Assoc. 2014;21:850-7. [PMID: 24578357] doi: 10.1136/amiajnl-2013-002411CrossrefMedlineGoogle Scholar
Muller CJ, MacLehose RF. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. Int J Epidemiol. 2014;43:962-70. [PMID: 24603316] doi: 10.1093/ije/dyu029CrossrefMedlineGoogle Scholar
McCulloch CE, Neuhaus JM. Generalized linear mixed models.. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. 2nd ed. Chichester, UK: J Wiley; 2005:2085-9. Google Scholar
Barnett ML, Linder JA. Antibiotic prescribing for adults with acute bronchitis in the United States, 1996–2010. JAMA. 2014;311:2020-2. [PMID: 24846041] doi: 10.1001/jama.2013.286141CrossrefMedlineGoogle Scholar
Barnett ML, Linder JA. Antibiotic prescribing to adults with sore throat in the United States, 1997–2010. JAMA Intern Med. 2014;174:138-40. [PMID: 24091806] doi: 10.1001/jamainternmed.2013.11673CrossrefMedlineGoogle Scholar
Fairlie T, Shapiro DJ, Hersh AL, Hicks LA. National trends in visit rates and antibiotic prescribing for adults with acute sinusitis [Letter]. Arch Intern Med. 2012;172:1513-4. [PMID: 23007315] doi: 10.1001/archinternmed.2012.4089CrossrefMedlineGoogle Scholar
Steinman MA, Yang KY, Byron SC, Maselli JH, Gonzales R. Variation in outpatient antibiotic prescribing in the United States. Am J Manag Care. 2009;15:861-8. [PMID: 20001167] MedlineGoogle Scholar
Zhang Y, Steinman MA, Kaplan CM. Geographic variation in outpatient antibiotic prescribing among older adults. Arch Intern Med. 2012;172:1465-71. [PMID: 23007171] doi: 10.1001/archinternmed.2012.3717CrossrefMedlineGoogle Scholar
Ackerman S, Gonzales R. The context of antibiotic overuse [Editorial]. Ann Intern Med. 2012;157:211-2. [PMID: 22868840] doi: 10.7326/0003-4819-157-3-201208070-00013LinkGoogle Scholar
Jenkins SG, Farrell DJ. Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis. 2009;15:1260-4. [PMID: 19751588] doi: 10.3201/eid1508.081187CrossrefMedlineGoogle Scholar
Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881-90. [PMID: 22591294] doi: 10.1056/NEJMoa1003833CrossrefMedlineGoogle Scholar
Gonzales R, Barrett PH Jr, Crane LA, Steiner JF. Factors associated with antibiotic use for acute bronchitis. J Gen Intern Med. 1998;13:541-8. [PMID: 9734791] CrossrefMedlineGoogle Scholar
Franck AJ, Smith RE. Antibiotic use for acute upper respiratory tract infections in a veteran population. J Am Pharm Assoc (2003). 2010;50:726-9. [PMID: 21071318] doi: 10.1331/JAPhA.2010.09103CrossrefMedlineGoogle Scholar
Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:CD000259. [PMID: 22696318] doi: 10.1002/14651858.CD000259.pub3CrossrefMedlineGoogle Scholar
Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al; Infectious Diseases Society of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77. [PMID: 17173212] CrossrefMedlineGoogle Scholar
Author, Article and Disclosure Information
From Veterans Affairs Salt Lake City Health Care System and University of Utah, and Salt Lake City, Utah; Veterans Affairs Kansas City Health Care System, Kansas City, Missouri; Veterans Affairs Greater Los Angeles Healthcare System and David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California; U.S. Department of Veterans Affairs, Hines, Illinois; and Centers for Disease Control and Prevention, Atlanta, Georgia.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the U.S. Department of Veterans Affairs, Centers for Disease Control and Prevention, or U.S. government.
Acknowledgment: The authors thank Saundra Duffy-Hawkins for administrative support, Jenny Teng for data collection and management, and Qing Zeng-Treitler and Douglas Redd for natural language processing.
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-1933.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer.
Grant Support: From the U.S. Department of Veterans Affairs through the Informatics Decision Enhancement and Analytic Sciences 2.0 Center of Innovation (IDEAS 2.0: CIN 14-267) and the Centers for Disease Control and Prevention Get Smart Project (14FED1412883).
Reproducible Research Statement:Study protocol and statistical code: Available from Dr. Jones (e-mail, barbara.
Corresponding Author: Barbara Ellen Jones, MD, MSc, George E. Wahlen Department of Veterans Affairs Medical Center, Informatics, Decision-Enhancement and Analytic Sciences Center, 500 Foothill Boulevard, Mail Code 182, Salt Lake City, UT 84148; e-mail, barbara.
Current Author Addresses: Drs. B.E. Jones, Sauer, M.M. Jones, and Samore and Mr. He: George E. Wahlen Department of Veterans Affairs Medical Center, Informatics, Decision-Enhancement and Analytic Sciences Center, 500 Foothill Boulevard, Mail Code 182, Salt Lake City, UT 84148.
Dr. Campo: Division of Infectious Disease, Knapp Medical Group, 2602 South Westgate Drive, Weslaco, TX 78596.
Dr. Damal: Kansas City Veterans Affairs Health Care System, 1490 Heritage Valley Drive, High Ridge, MO 63049.
Drs. Ying and Greene: Department of Epidemiology, University of Utah, 295 Chipeta Way, Salt Lake City, UT 84108.
Dr. Goetz: Veterans Affairs Greater Los Angeles Healthcare, 11301 Willshire Boulevard, Room 4669, Los Angeles, CA 90073.
Ms. Neuhauser: Pharmacy Benefits Management, Veterans Affairs Hines, 1st Avenue, 1 Block North of Cermac Road, Building 37, Room 139, Hines, IL 60141.
Dr. Hicks: Division of Bacterial Disease, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop C25, Atlanta, GA 30329.
Author Contributions: Conception and design: B.E. Jones, B. Sauer, M.M. Jones, J. Campo, L.A. Hicks, M.H. Samore.
Analysis and interpretation of the data: B.E. Jones, B. Sauer, M.M. Jones, J. Campo, K. Damal, T. He, J. Ying, T. Greene, M.B. Goetz, L.A. Hicks, M.H. Samore.
Drafting of the article: B.E. Jones, B. Sauer, M.M. Jones, J. Campo, K. Damal, J. Ying, L.A. Hicks, M.H. Samore.
Critical revision of the article for important intellectual content: B. Sauer, M.M. Jones, J. Campo, J. Ying, M.B. Goetz, M.M. Neuhauser, L.A. Hicks, M.H. Samore.
Final approval of the article: B.E. Jones, B. Sauer, M.M. Jones, J. Campo, K. Damal, J. Ying, M.B. Goetz, M.M. Neuhauser, L.A. Hicks, M.H. Samore.
Provision of study materials or patients: B. Sauer.
Statistical expertise: B. Sauer, K. Damal, J. Ying, T. Greene.
Obtaining of funding: M.M. Jones, L.A. Hicks, M.H. Samore.
Administrative, technical, or logistic support: B. Sauer, J. Campo.
Collection and assembly of data: B.E. Jones, B. Sauer, M.M. Jones, J. Campo, K. Damal, T. He, M.H. Samore.